Table 2 Clinical characteristics for included participants after a PFF combined and grouped by four recovery phases.
Total N = 505 | Acute n = 100 (20%) | Post-acute n = 117 (23%) | Extended Recovery n = 201 (40%) | Long-term Recovery n = 87 (17%) | |
|---|---|---|---|---|---|
TUG (s), mean (SD) | 19.8 (12.3) | - | 25.5 (15.7) | 17.5 (9) | 17.4 (11.6) |
SPPB | |||||
Total score [0–12], mean (SD) | 6.2 (3.1) | 3.5 (2.0) | 5.5 (2.6) | 7.3 (2.8) | 7.6 (3.3) |
Gait speed 4MWT (m/s), mean (SD) | 0.70 (0.40) | 0.36 (0.20) | 0.63 (0.22) | 0.79 (0.34) | 0.88 (0.38) |
6MinWT Distance (m), mean (SD) | 283.6 (125.9) | - | 225.8 (104.5) | 301.6 (124.4) | 317.5 (131.3) |
LLFDI-FC [0-100], median (p25-p75) | 49 (42–59) | - | 43 (40–49) | 51 (45–58) | 56 (46–65) |
Short FES-I [7–28], median (p25-p75) | 10 (7–14) | 10 (7–15) | 11 (8–15) | 9 (7–13) | 9 (7–12) |
FACIT-F [0–52], median (p25-p75) | 40 (31–45) | 36 (29–42) | 39 (30–44) | 41 (34–46) | 42 (33–46) |
Hearing Impairment [2–8], mean (SD) | 2.9 (1.2) | 3.1 (1.2) | 2.8 (1.1) | 2.9 (1.2) | 3.1 (1.2) |
Systolic Blood Pressure (mm Hg), median (p25-p75) | 132 (120–150) | 130 (120–153) | 130 (120–142) | 135 (122–151) | 136 (123–160) |